Spectral Medical Inc. (TSX:EDT)
1.300
0.00 (0.00%)
Feb 9, 2026, 4:00 PM EST
Spectral Medical Revenue
Spectral Medical had revenue of 675.00K CAD in the quarter ending September 30, 2025, with 34.46% growth. This brings the company's revenue in the last twelve months to 2.71M, up 34.85% year-over-year. In the year 2024, Spectral Medical had annual revenue of 2.29M with 43.05% growth.
Revenue (ttm)
2.71M
Revenue Growth
+34.85%
P/S Ratio
140.60
Revenue / Employee
93.28K
Employees
29
Market Cap
380.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.29M | 688.00K | 43.05% |
| Dec 31, 2023 | 1.60M | -69.00K | -4.14% |
| Dec 31, 2022 | 1.67M | -329.00K | -16.48% |
| Dec 31, 2021 | 2.00M | -105.00K | -5.00% |
| Dec 31, 2020 | 2.10M | -767.00K | -26.74% |
| Dec 31, 2019 | 2.87M | -972.00K | -25.31% |
| Dec 31, 2018 | 3.84M | 171.00K | 4.66% |
| Dec 31, 2017 | 3.67M | 124.00K | 3.50% |
| Dec 31, 2016 | 3.55M | 456.00K | 14.76% |
| Dec 31, 2015 | 3.09M | 125.00K | 4.22% |
| Dec 31, 2014 | 2.96M | 292.00K | 10.93% |
| Dec 31, 2013 | 2.67M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSpectral Medical News
- 2 months ago - Spectral Medical Inc. (EDT:CA) Discusses Year-End Update: FDA Filing Timeline, Tigris Trial Results, and Commercialization Readiness Transcript - Seeking Alpha
- 3 months ago - Spectral Medical GAAP EPS of -$0.11, revenue of $0.6M - Seeking Alpha
- 4 months ago - Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF - GlobeNewsWire
- 5 months ago - Spectral Medical Announces Publication of EDEN Observational Study - GlobeNewsWire
- 5 months ago - Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025 - GlobeNewsWire
- 6 months ago - Spectral Medical Receives US$3 Million From Vantive - GlobeNewsWire
- 6 months ago - Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock - GlobeNewsWire
- 6 months ago - Spectral Medical GAAP EPS of $0.00, revenue of $0.81M - Seeking Alpha